LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

NCT03103087 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

382

Enrollment

INDUSTRY

Sponsor class

Conditions

Heavy Menstrual Bleeding
Uterine Fibroid

Interventions

DRUG: Relugolix
DRUG: Estradiol/norethindrone acetate
DRUG: Relugolix placebo
DRUG: Estradiol/norethindrone acetate placebo

Sponsor

Myovant Sciences GmbH